The ultra long-term treatment of senile osteoporosis with 1 alpha-hydroxyvitamin D3 (Q70708506)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8490326%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

title

The ultra long-term treatment of senile osteoporosis with 1 alpha-hydroxyvitamin D3 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8490326%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

author name string

M Shiraki

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8490326%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

H Ito

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8490326%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

H Orimo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8490326%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

publication date

1 March 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8490326%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8490326%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8490326%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8490326%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

page(s)

223-234

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8490326%20AND%20SRC:MED&resulttype=core&format=json

Involutional osteoporosis

13 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980003-7

7 January 2021

Osteoporosis and the risk of hip fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980003-7

7 January 2021

Bone densitometry and clinical decision-making in osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980003-7

7 January 2021

Long-term treatment of postmenopausal osteoporosis with active vitamin D3, 1-alpha-hydroxycholecalciferol (1 alpha-OHD3) and 1, 24 Dihydroxycholecalciferol (1, 24(OH)2D3).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980003-7

7 January 2021

Treatment of osteoporosis with 1-alpha-hydroxycholecalciferol and calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980003-7

7 January 2021

1,25(OH)2 vitamin D3 in osteoporosis--a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980003-7

7 January 2021

1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980003-7

7 January 2021

Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980003-7

7 January 2021

Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980003-7

7 January 2021

Calcitriol treatment is not effective in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980003-7

7 January 2021

1-34 Human parathyroid hormone radioimmunoassay: Properties of antiserum against synthetic 1-34 human parathyroid hormone and its clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980003-7

7 January 2021

[Clinical studies using a highly sensitive radioimmunoassay for mid-region and carboxy terminus of parathyroid hormone in normal, hypo- and hypercalcemic states]

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980003-7

7 January 2021

Radioreceptor assay for 1 alpha,24(R)25-trihydroxyvitamin D3 in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980003-7

7 January 2021

Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980003-7

7 January 2021

Deficient Production of 1,25-Dihydroxyvitamin D in Elderly Osteoporotic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980003-7

7 January 2021

The influence of age on the intestinal absorption of 47-Ca absorption in post-menopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980003-7

7 January 2021

Vitamin D toxicity complicating the treatment of senile, postmenopausal, and glucocorticoid-induced osteoporosis. Four case reports and a critical commentary on the use of vitamin D in these disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980003-7

7 January 2021

Treatment of postmenopausal osteoporosis with calcitriol or calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980003-7

7 January 2021

Direct effects of vitamin D and its metabolites on skeletal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980003-7

7 January 2021

10.1016/S0169-6009(08)80003-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8490326%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference